Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ruidi Jiao"'
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 14, Iss 1, Pp 1-15 (2024)
Esophageal cancer is an upper gastrointestinal malignancy with a bleak prognosis. It is still being explored in depth due to its complex molecular mechanisms of occurrence and development. Lipids play a crucial role in cells by participating in energ
Externí odkaz:
https://doaj.org/article/7710fbc3c62043b0a37e73b35caba0d0
Publikováno v:
Thoracic Cancer, Vol 12, Iss 6, Pp 899-905 (2021)
Abstract Background Stereotactic ablative radiotherapy (SABR) is the current standard‐of‐care in cases of inoperable early stage non‐small cell lung cancer (ES‐NSCLC). This study aimed to assess the survival outcomes and recurrence patterns a
Externí odkaz:
https://doaj.org/article/17341894980443bb9edc7f8a5537971c
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Indoleamine 2,3-dioxygenase (IDO1) plays an important role in tumor immune evasion. In this study, we investigated the changes of tumor IDO1 expression and CD8+ tumor-infiltrating lymphocytes (TILs) status in tumor microenvironment (TME) after neoadj
Externí odkaz:
https://doaj.org/article/8cbc8aa126b449bca65259a1b385cb99
Autor:
Donghai Hou, Yi Liu, Feng Qi, Wenbo Xu, Ruidi Jiao, Zhengjun Kang, Yinghao Zhang, Lizhuan Zheng
Publikováno v:
Precision Medical Sciences. 9:31-42
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0974468b5dbd2bc11eee4075f4c0a3a
https://doi.org/10.1002/prm2.12007
https://doi.org/10.1002/prm2.12007
Autor:
Ruidi Jiao, Hui Luo, Zhuo Feng, Shuai Song, Hong Ge, Ronghu Mao, Nan Wang, Peizan Ni, Qiang Gao, Hengli Song
Publikováno v:
Cancer Science
Overcoming resistance to radiation is a great challenge in cancer therapy. Here, we highlight that targeting valosin‐containing protein (VCP) improves radiation sensitivity in esophageal squamous cell carcinoma (ESCC) cell lines and show the potent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8155bb61f0d90b06c7021d5fa434afb
http://europepmc.org/articles/PMC6825005
http://europepmc.org/articles/PMC6825005
Publikováno v:
OncoTargets and Therapy. 12:6023-6032
Esophageal squamous cell carcinoma (ESCC) is one of the common malignant tumors in the world. More than half of patients with ESCC were detected in advanced or metastatic disease at the time of initial diagnosis and lost the opportunities of surgery.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eeb8c8f0cb0ab448db940e153aa69689
https://doi.org/10.2147/ott.s214579
https://doi.org/10.2147/ott.s214579
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 6, Pp 899-905 (2021)
Thoracic Cancer, Vol 12, Iss 6, Pp 899-905 (2021)
Background Stereotactic ablative radiotherapy (SABR) is the current standard‐of‐care in cases of inoperable early stage non‐small cell lung cancer (ES‐NSCLC). This study aimed to assess the survival outcomes and recurrence patterns after SABR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb24facc17fbaea557c04ad493a4e07d
https://pubmed.ncbi.nlm.nih.gov/33529496
https://pubmed.ncbi.nlm.nih.gov/33529496
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
Indoleamine 2,3-dioxygenase (IDO1) plays an important role in tumor immune evasion. In this study, we investigated the changes of tumor IDO1 expression and CD8+ tumor-infiltrating lymphocytes (TILs) status in tumor microenvironment (TME) after neoadj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17c8aff0862bdb5750e093dfde08f8c2
Publikováno v:
OncoTargets and therapy
Esophageal squamous cell carcinoma (ESCC) is one of the common malignant tumors in the world. More than half of patients with ESCC were detected in advanced or metastatic disease at the time of initial diagnosis and lost the opportunities of surgery.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2777d58775143b6c606204e4a3fefe8d
https://pubmed.ncbi.nlm.nih.gov/31551657
https://pubmed.ncbi.nlm.nih.gov/31551657